Announcements Trials
Browse Landscape

Phase

Phase 3 7Phase 2 7Phase NA 2Phase 1 2

Status

Completed 3Unknown 2Active not recruiting 2

Sponsor Class

OTHER 5INDUSTRY 2

Study Type

Interventional 7

Sponsor

Cancer Type

Thoracic 10Gynecologic 7Breast 5Dermatologic 2Gastrointestinal 1

Conditions

Ovarian Neoplasms 6Fallopian Tube Neoplasms 3Carcinoma, Ovarian Epithelial 3Recurrence 1Neoplasm Metastasis 1Endometrial Neoplasms 1

Interventions

Paclitaxel 150Carboplatin 110Cisplatin 94Bevacizumab 42Topotecan 39Gemcitabine 38liposomal doxorubicin 34Radiotherapy 29Doxorubicin 27Brachytherapy 26Taxes 24pembrolizumab 20olaparib 20Drug Therapy 20Hyperthermic Intraperitoneal Chemotherapy 16Chemotherapy, Adjuvant 16human papillomavirus vaccine, L1 type 16, 18 15Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 14Docetaxel 13Neoadjuvant Therapy 12Platinum 10niraparib 9Radiation 91,2-diaminocyclohexaneplatinum II citrate 9Vaccines, Synthetic 8Surgical Procedures, Operative 8atezolizumab 7Specimen Handling 7Papillomavirus Vaccines 7Letrozole 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Phase 3 × CP protocol × Gynecologic × Clear all
NCT05201547 2025-12-04

DOMENICA

ARCAGY/ GINECO GROUP

Phase 3 Active not recruiting
260 enrolled
Gynecologic

Neoplasm Metastasis, Endometrial Neoplasms

NCT03737643 2025-01-29

DUO-O

AstraZeneca

Phase 3 Active not recruiting
1,407 enrolled 1 FDA
Gynecologic

Ovarian Neoplasms

NCT02855944 2023-06-09

ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients

pharmaand GmbH

Phase 3 Completed
349 enrolled 29 charts
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms, Recurrence

NCT05371301 2022-05-12

Efficacy of Primary Debulking Surgery Versus Neoadjuvant Chemotherapy in Stage IV Ovarian Cancer

Fudan University

Phase 3 Unknown
200 enrolled
Gynecologic

Ovarian Neoplasms

NCT04337632 2021-04-08

Evaluation of the Sensitivity to Different Chemotherapy Regimens in Platinum-Partial Sensitive Recurrent Ovarian Cancer

Hunan Cancer Hospital

Phase 3 Unknown
338 enrolled
Gynecologic

Ovarian Neoplasms

NCT00226915 2020-02-17

Trial of Tri-weekly TJ Versus Weekly TJ for Stage II-IV Mullerian Carcinoma

Japanese Gynecologic Oncology Group

Phase 3 Completed
637 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00052468 2014-06-25

AGO-OVAR9

AGO Study Group

Phase 3 Completed
1,742 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡